Abstract

Currently, atherosclerosis, which affects the vascular bed of all vital organs and tissues, is considered as a leading cause of death. Most commonly, atherosclerosis involves coronary and peripheral arteries, which results in acute (e.g., myocardial infarction, lower extremities ischemia) or chronic (persistent ischemia leading to severe heart failure) consequences. All of them have a marked unfavorable impact on the quality of life and are associated with increased mortality and morbidity in human populations. Lower extremity artery disease (LEAD, also defined as peripheral artery disease, PAD) refers to atherosclerotic occlusive disease of the lower extremities, where partial or complete obstruction of peripheral arteries is observed. Decreased perfusion can result in ischemic pain, non-healing wounds, and ischemic ulcers, and significantly reduce the quality of life. However, the progressive atherosclerotic changes cause stimulation of tissue response processes, like vessel wall remodeling and neovascularization. These mechanisms of adapting the vascular network to pathological conditions seem to play a key role in reducing the impact of the changes limiting the flow of blood. Neovascularization as a response to ischemia induces sprouting and expansion of the endothelium to repair and grow the vessels of the circulatory system. Neovascularization consists of three different biological processes: vasculogenesis, angiogenesis, and arteriogenesis. Both molecular and environmental factors that may affect the process of development and growth of blood vessels were analyzed. Particular attention was paid to the changes taking place during LEAD. It is important to consider the molecular mechanisms underpinning vessel growth. These mechanisms will also be examined in the context of diseases commonly affecting blood vessel function, or those treatable in part by manipulation of angiogenesis. Furthermore, it may be possible to induce the process of blood vessel development and growth to treat peripheral vascular disease and wound healing. Reactive oxygen species (ROS) play an important role in regulation of essential cellular signaling pathways such as cell differentiation, proliferation, migration and apoptosis. With regard to the repair processes taking place during diseases such as LEAD, prospective therapeutic methods have been described that could significantly improve the treatment of vessel diseases in the future. Summarizing, regenerative medicine holds the potential to transform the therapeutic methods in heart and vessel diseases treatment.

Highlights

  • The vascular network is essential for delivery of oxygen and nutrients, as well as removal of carbon dioxide and metabolic waste products from different tissues

  • The authors found a higher frequency of +405 CC and −2578 CC genotypes in the claudication group, while the presence of +405 GG and −2578 AA genotypes was more common among critical limb ischemia patients

  • Endothelial cells’ ability to grow in hypoxic environments may be linked to the fact that bi-directional ATP synthase is present on the plasma membrane of these cells, allowing endothelial cells (ECs) to maintain a high level of intracellular ATP [118]

Read more

Summary

Introduction

The vascular network is essential for delivery of oxygen and nutrients, as well as removal of carbon dioxide and metabolic waste products from different tissues. The body must have mechanisms to circumvent impairment or injury to the network The expansion of this network in response to low availability of nutrients or oxygen is known as angiogenesis, a vital process regulated by signaling molecules such as vascular endothelial growth factor (VEGF). Lymphangiogenesis describes a similar process of repair and expansion in the lymphatic system, while vasculogenesis refers to the differentiation of angioblast precursors into endothelial cells, and subsequent establishment of primitive vessels and vessel networks [2]. The secretome of mesenchymal stromal cells (MSCs), as well as that of adipose-derived stem cells (ASCs), is known to contain pro-angiogenic miRNAs and growth factors, which can induce angiogenesis to enhance wound healing, cardiomyopathies and peripheral artery disease

Peripheral Arterial Disease
Molecular Basis of Vessel Disease
Neovascularization
Vasculogenesis
Angiogenesis
Arteriogenesis
Hypoxia
Inflammation
Angiogenic and Arteriogenic Growth Factors
Angiopoietin
Non-Coding RNAs in Neovascularization
Vasculogenesis and Lymphangiogenesis
Mechanisms of Neovascularization and Cell-Based Therapies
Endothelial Cell Sprouting
Stem Cell Therapy and Angiogenesis
Molecular Association with Traditional Therapies in LEAD
Findings
Conclusions
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call